Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes
Date
2024
Authors
Lim, J.
Ross, D.M.
Brown, A.L.
Scott, H.S.
Hahn, C.N.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Leukemia Research, 2024; 146(107566):1-10
Statement of Responsibility
Conference Name
Abstract
Epidemiological evidence of familial predispositions to myeloid malignancies and myeloproliferative neoplasms (MPN) has long been recognised, but recent studies have added to knowledge of specific germline variants in multiple genes that contribute to the familial risk. These variants may be common risk alleles in the general population but have low penetrance and cause sporadic MPN, such as the JAK2 46/1 haplotype, the variant most strongly associated with MPN. Association studies are increasingly identifying other MPN susceptibility genes such as TERT, MECOM, and SH2B3, while some common variants in DDX41 and RUNX1 appear to lead to a spectrum of myeloid malignancies.
RBBP6 and ATM variants have been identified in familial MPN clusters and very rare germline variants such as chromosome 14q duplication cause hereditary MPN with high penetrance. Rarely, there are hereditary non-malignant diseases with an MPN-like phenotype. Knowledge of those genes and germline genetic changes which lead to MPN or diseases that mimic MPN helps to improve accuracy of diagnosis, aids with counselling regarding familial risk, and may contribute to clinical decision-making. Large scale population exome and genome sequencing studies will improve our knowledge of both common and rare germline genetic contributions to MPN.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Access Condition Notes: Accepted manuscript available after 01 October 2025